Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Computers in Biology and Medicine
|
July 5, 2025
In silico screening of a designed focused chemical space identifies novel alkyl hydrazides as potent HDAC11 inhibitors
Fady Baselious, Sebastian Hilscher, Lukas Handke, et al.
International Journal of Molecular Sciences
|
January 27, 2024
Comparative Structure-Based Virtual Screening Utilizing Optimized AlphaFold Model Identifies Selective HDAC11 Inhibitor
Fady Baselious, Sebastian Hilscher, Dina Robaa, et al.
ACS Omega
|
November 3, 2025
Substrate-Guided Development of HDAC11-Selective Inhibitors Featuring α‑Amino Amide Zinc-Binding Groups
Sebastian Hilscher, Marat Meleshin, Fady Baselious, et al.
International Journal of Molecular Sciences
|
April 28, 2023
Continuous Fluorescent Sirtuin Activity Assay Based on Fatty Acylated Lysines
Matthes Zessin, Marat Meleshin, Sebastian Hilscher, et al.
Archiv Der Pharmazie
|
July 12, 2024
Utilization of an optimized AlphaFold protein model for structure-based design of a selective HDAC11 inhibitor with anti-neuroblastoma activity
Fady Baselious, Sebastian Hilscher, Sven Hagemann, et al.
Archiv Der Pharmazie
|
September 18, 2024
Development of new pyrazoles as class I HDAC inhibitors: Synthesis, molecular modeling, and biological characterization in leukemia cells
Francesco Berluti, Fady Baselious, Sven Hagemann, et al.
Archiv Der Pharmazie
|
November 6, 2023
Design and synthesis of bioreductive prodrugs of class I histone deacetylase inhibitors and their biological evaluation in virally transfected acute myeloid leukemia cells
Mohamed Abdelsalam, Mariia Zmyslia, Karin Schmidtkunz, et al.
Bioorganic Chemistry
|
April 19, 2025
Unlocking the potential of novel tetrahydro-β-carboline-based HDAC6 inhibitors for colorectal cancer therapy: Design, synthesis and biological evaluation
Noreen Hemida, Dalia S El-Gamil, Ahmed K ElHady, et al.
RSC Medicinal Chemistry
|
April 21, 2025
Development of potent and selective tetrahydro-β-carboline-based HDAC6 inhibitors with promising activity against triple-negative breast cancer
Aya Fathy, Amro Allam, Ahmed K ElHady, et al.
ACS Omega
|
February 16, 2026
Capsaicin-Inspired Hydroxamate Hybrids as Selective HDAC6 Inhibitors with Antiproliferative Activity in Hematological Malignancies
Lara Gimenez Borges, Thais Nascimento de Oliveira Alves, Sandra Valeria Vassiliades, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Computers in Biology and Medicine
|
July 5, 2025
In silico screening of a designed focused chemical space identifies novel alkyl hydrazides as potent HDAC11 inhibitors
Fady Baselious, Sebastian Hilscher, Lukas Handke, et al.
International Journal of Molecular Sciences
|
January 27, 2024
Comparative Structure-Based Virtual Screening Utilizing Optimized AlphaFold Model Identifies Selective HDAC11 Inhibitor
Fady Baselious, Sebastian Hilscher, Dina Robaa, et al.
ACS Omega
|
November 3, 2025
Substrate-Guided Development of HDAC11-Selective Inhibitors Featuring α‑Amino Amide Zinc-Binding Groups
Sebastian Hilscher, Marat Meleshin, Fady Baselious, et al.
International Journal of Molecular Sciences
|
April 28, 2023
Continuous Fluorescent Sirtuin Activity Assay Based on Fatty Acylated Lysines
Matthes Zessin, Marat Meleshin, Sebastian Hilscher, et al.
Archiv Der Pharmazie
|
July 12, 2024
Utilization of an optimized AlphaFold protein model for structure-based design of a selective HDAC11 inhibitor with anti-neuroblastoma activity
Fady Baselious, Sebastian Hilscher, Sven Hagemann, et al.
Archiv Der Pharmazie
|
September 18, 2024
Development of new pyrazoles as class I HDAC inhibitors: Synthesis, molecular modeling, and biological characterization in leukemia cells
Francesco Berluti, Fady Baselious, Sven Hagemann, et al.
Archiv Der Pharmazie
|
November 6, 2023
Design and synthesis of bioreductive prodrugs of class I histone deacetylase inhibitors and their biological evaluation in virally transfected acute myeloid leukemia cells
Mohamed Abdelsalam, Mariia Zmyslia, Karin Schmidtkunz, et al.
Bioorganic Chemistry
|
April 19, 2025
Unlocking the potential of novel tetrahydro-β-carboline-based HDAC6 inhibitors for colorectal cancer therapy: Design, synthesis and biological evaluation
Noreen Hemida, Dalia S El-Gamil, Ahmed K ElHady, et al.
RSC Medicinal Chemistry
|
April 21, 2025
Development of potent and selective tetrahydro-β-carboline-based HDAC6 inhibitors with promising activity against triple-negative breast cancer
Aya Fathy, Amro Allam, Ahmed K ElHady, et al.
ACS Omega
|
February 16, 2026
Capsaicin-Inspired Hydroxamate Hybrids as Selective HDAC6 Inhibitors with Antiproliferative Activity in Hematological Malignancies
Lara Gimenez Borges, Thais Nascimento de Oliveira Alves, Sandra Valeria Vassiliades, et al.
Page
of 2